Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trial
已完结10由 wlm 发布于 2026/4/23 11:40:43
DOI:10.1016/j.chest.2025.12.055
作者:Li-Xiu He, Ling Yang, Zu-Ke Xiao, Rong Qiu, Fa-Ming Yu, Li-Qin Wu, Wei-Hua Zhang, Xun-Chao Liu, Ling-Feng Min, Xiu-Qin Ma, Jian-Zhong Jiang, Bo Yuan, Ran-Ran Dai, Dong Liu, Xiao-Hua Li, Tao Wang, Jie
文献类型:期刊论文
补充材料:只需要正文